{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T21:43:55Z","timestamp":1780609435265,"version":"3.54.1"},"reference-count":50,"publisher":"Japan Atherosclerosis Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2023,9,1]]},"DOI":"10.5551\/jat.63891","type":"journal-article","created":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T22:11:09Z","timestamp":1672265469000},"page":"1210-1288","source":"Crossref","is-referenced-by-count":14,"title":["Cardiovascular Risk Factor Burden and Treatment Control in Patients with Chronic Kidney Disease: A Cross-Sectional Study"],"prefix":"10.5551","volume":"30","author":[{"given":"Hiromasa","family":"Kitamura","sequence":"first","affiliation":[{"name":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Hiyamuta","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, Division of Nephrology and Rheumatology, Fukuoka University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Shimamoto","sequence":"additional","affiliation":[{"name":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Tsuruya","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Nara Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Nakano","sequence":"additional","affiliation":[{"name":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanari","family":"Kitazono","sequence":"additional","affiliation":[{"name":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","unstructured":"1) Foley RN, Parfrey PS and Sarnak MJ: Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol, 1998; 9: S16-23"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Go AS, Chertow GM, Fan D, McCulloch CE and Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med, 2004; 351: 1296-1305","DOI":"10.1056\/NEJMoa041031"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Manjunath G, Tighiouart H, Ibrahim H, MacLeod B, Salem DN, Griffith JL, Coresh J, Levey AS and Sarnak MJ: Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. Journal of the American College of Cardiology, 2003; 41: 47-55","DOI":"10.1016\/S0735-1097(02)02663-3"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Thompson S, James M, Wiebe N, Hemmelgarn B, Manns B, Klarenbach S, Tonelli M and Alberta Kidney Disease Network: Cause of Death in Patients with Reduced Kidney Function. J Am Soc Nephrol, 2015; 26: 2504-2511","DOI":"10.1681\/ASN.2014070714"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Tanaka K, Watanabe T, Takeuchi A, Ohashi Y, Nitta K, Akizawa T, Matsuo S, Imai E, Makino H, Hishida A; CKD-JAC Investigators: Cardiovascular events and death in Japanese patients with chronic kidney disease. Kidney Int, 2017; 91: 227-234","DOI":"10.1016\/j.kint.2016.09.015"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Wakasugi M, Narita I, Iseki K, Asahi K, Yamagata K, Fujimoto S, Moriyama T, Konta T, Tsuruya K, Kasahara M, Shibagaki Y, Kondo M and Watanabe T: The Effect of CKD on Associations between Lifestyle Factors and All-cause, Cancer, and Cardiovascular Mortality: A Population-based Cohort Study. Intern Med, 2021; 60: 2189-2200","DOI":"10.2169\/internalmedicine.6531-20"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Ninomiya T, Kiyohara Y, Kubo M, Tanizaki Y, Doi Y, Okubo K, Wakugawa Y, Hata J, Oishi Y, Shikata K, Yonemoto K, Hirakata H and Iida M: Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study. Kidney Int, 2005; 68: 228-236","DOI":"10.1111\/j.1523-1755.2005.00397.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Wilson PW, Castelli WP and Kannel WB: Coronary risk prediction in adults (the Framingham Heart Study). Am J Cardiol, 1987; 59: 91G-94G","DOI":"10.1016\/0002-9149(87)90165-2"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Di Angelantonio E, Danesh J, Eiriksdottir G and Gudnason V: Renal function and risk of coronary heart disease in general populations: new prospective study and systematic review. PLoS Med, 2007; 4: e270","DOI":"10.1371\/journal.pmed.0040270"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Abramson JL, Jurkovitz CT, Vaccarino V, Weintraub WS and McClellan W: Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: the ARIC Study. Kidney Int, 2003; 64: 610-615","DOI":"10.1046\/j.1523-1755.2003.00109.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW; American Heart Association Councils on Kidney in Cardiovascular Disease High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention: Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation, 2003; 108: 2154-2169","DOI":"10.1161\/01.CIR.0000095676.90936.80"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Iso H, Cui R, Date C, Kikuchi S, Tamakoshi A; JACC Study Group: C-reactive protein levels and risk of mortality from cardiovascular disease in Japanese: the JACC Study. Atherosclerosis, 2009; 207: 291-297","DOI":"10.1016\/j.atherosclerosis.2009.04.020"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Sung KC, Ryu S, Chang Y, Byrne CD and Kim SH: C-reactive protein and risk of cardiovascular and all-cause mortality in 268 803 East Asians. Eur Heart J, 2014; 35: 1809-1816","DOI":"10.1093\/eurheartj\/ehu059"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Lee C, Park KH, Joo YS, Nam KH, Chang TI, Kang EW, Lee J, Oh YK, Jung JY, Ahn C, Lee KB, Park JT, Yoo TH, Kang SW and Han SH: Low High-Sensitivity C-Reactive Protein Level in Korean Patients With Chronic Kidney Disease and Its Predictive Significance for Cardiovascular Events, Mortality, and Adverse Kidney Outcomes: Results From KNOW-CKD. J Am Heart Assoc, 2020; 9: e017980","DOI":"10.1161\/JAHA.120.017980"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Goicoechea M, de Vinuesa SG, Verdalles U, Ruiz-Caro C, Ampuero J, Rinc\u00f3n A, Arroyo D and Lu\u00f1o J: Effect of allopurinol in chronic kidney disease progression and cardiovascular risk. Clin J Am Soc Nephrol, 2010; 5: 1388-1393","DOI":"10.2215\/CJN.01580210"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Goicoechea M, Garcia de Vinuesa S, Verdalles U, Verde E, Macias N, Santos A, P\u00e9rez de Jose A, Cede\u00f1o S, Linares T and Lu\u00f1o J: Allopurinol and progression of CKD and cardiovascular events: long-term follow-up of a randomized clinical trial. Am J Kidney Dis, 2015; 65: 543-549","DOI":"10.1053\/j.ajkd.2014.11.016"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Korgaonkar S, Tilea A, Gillespie BW, Kiser M, Eisele G, Finkelstein F, Kotanko P, Pitt B and Saran R: Serum potassium and outcomes in CKD: insights from the RRI-CKD cohort study. Clin J Am Soc Nephrol, 2010; 5: 762-769","DOI":"10.2215\/CJN.05850809"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Luo J, Brunelli SM, Jensen DE and Yang A: Association between Serum Potassium and Outcomes in Patients with Reduced Kidney Function. Clin J Am Soc Nephrol, 2016; 11: 90-100","DOI":"10.2215\/CJN.01730215"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Foster MC, Rawlings AM, Marrett E, Neff D, Willis K, Inker LA, Coresh J and Selvin E: Cardiovascular risk factor burden, treatment, and control among adults with chronic kidney disease in the United States. Am Heart J, 2013; 166: 150-156","DOI":"10.1016\/j.ahj.2013.03.016"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Jankowski J, Floege J, Fliser D, Bohm M and Marx N: Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options. Circulation, 2021; 143: 1157-1172","DOI":"10.1161\/CIRCULATIONAHA.120.050686"},{"key":"21","unstructured":"21) Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group: KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl, 2013; 3: 1-150"},{"key":"22","unstructured":"22) Japanese Society of Nephrology: Evidence-based practice guideline for the treatment of CKD. Nihon Jinzo Gakkai Shi, 2018; 60: 1037-1193 (in Japanese)"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Selvarajah S, van der Graaf Y, Visseren FL, Bots ML; SMART study group: Cardiovascular risk factor treatment targets and renal complications in high risk vascular patients: a cohort study. BMC Cardiovasc Disord, 2011; 11: 40","DOI":"10.1186\/1471-2261-11-40"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Muntner P, Anderson A, Charleston J, Chen Z, Ford V, Makos G, O\u2019Connor A, Perumal K, Rahman M, Steigerwalt S, Teal V, Townsend R, Weir M and Wright JT, Jr.: Hypertension awareness, treatment, and control in adults with CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis, 2010; 55: 441-451","DOI":"10.1053\/j.ajkd.2009.09.014"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Tanaka S, Ninomiya T, Fujisaki K, Yoshida H, Nagata M, Masutani K, Tokumoto M, Mitsuiki K, Hirakata H, Fujimi S, Kiyohara Y, Kitazono T, Tsuruya K; Fukuoka Kidney disease Registry Study Collaboration Group: The Fukuoka Kidney disease Registry (FKR) Study: design and methods. Clin Exp Nephrol, 2017; 21: 465-473","DOI":"10.1007\/s10157-016-1294-4"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Arase H, Yamada S, Tanaka S, Tokumoto M, Tsuruya K, Nakano T and Kitazono T: Association Between Plasma Intact Parathyroid Hormone Levels and the Prevalence of Atrial Fibrillation in Patients With Chronic Kidney Disease- The Fukuoka Kidney Disease Registry Study. Circ J, 2020; 84: 1105-1111","DOI":"10.1253\/circj.CJ-19-1201"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Tanaka S, Nakano T, Hiyamuta H, Tsuruya K, Kitazono T; FKR Study Collaboration Group: Association between Multimorbidity and Kidney Function among Patients with Non-Dialysis-Dependent CKD. J Atheroscler Thromb, 2022; 29: 1249-1264","DOI":"10.5551\/jat.62900"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H and Hishida A: Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis, 2009; 53: 982-992","DOI":"10.1053\/j.ajkd.2008.12.034"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, Horio T, Hoshide S, Ikeda S, Ishimitsu T, Ito M, Ito S, Iwashima Y, Kai H, Kamide K, Kanno Y, Kashihara N, Kawano Y, Kikuchi T, Kitamura K, Kitazono T, Kohara K, Kudo M, Kumagai H, Matsumura K, Matsuura H, Miura K, Mukoyama M, Nakamura S, Ohkubo T, Ohya Y, Okura T, Rakugi H, Saitoh S, Shibata H, Shimosawa T, Suzuki H, Takahashi S, Tamura K, Tomiyama H, Tsuchihashi T, Ueda S, Uehara Y, Urata H and Hirawa N: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019). Hypertens Res, 2019; 42: 1235-1481","DOI":"10.1038\/s41440-019-0284-9"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Haneda M, Noda M, Origasa H, Noto H, Yabe D, Fujita Y, Goto A, Kondo T and Araki E: Japanese Clinical Practice Guideline for Diabetes 2016. Diabetol Int, 2018; 9: 1-45","DOI":"10.1007\/s13340-018-0345-3"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Kinoshita M, Yokote K, Arai H, Iida M, Ishigaki Y, Ishibashi S, Umemoto S, Egusa G, Ohmura H, Okamura T, Kihara S, Koba S, Saito I, Shoji T, Daida H, Tsukamoto K, Deguchi J, Dohi S, Dobashi K, Hamaguchi H, Hara M, Hiro T, Biro S, Fujioka Y, Maruyama C, Miyamoto Y, Murakami Y, Yokode M, Yoshida H, Rakugi H, Wakatsuki A, Yamashita S; Committee for Epidemiology and Clinical Management of Atherosclerosis: Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017. J Atheroscler Thromb, 2018; 25: 846-984","DOI":"10.5551\/jat.GL2017"},{"key":"32","unstructured":"32) Japan Atherosclerosis Society: Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022 (in Japanese)"},{"key":"33","unstructured":"33) Japan Society for the Study of Obesity: Guidelines for the management of obesity disease 2016, Life Science Publishing, Japan, 2016 (in Japanese)"},{"key":"34","unstructured":"34) World Health Organization: Obesity and overweight fact sheet, 2020. Available at: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight. Accessed September 27, 2022"},{"key":"35","unstructured":"35) Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group: KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease. Kidney Int Suppl, 2012; 2: 288-335"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Arima H, Kubo M, Yonemoto K, Doi Y, Ninomiya T, Tanizaki Y, Hata J, Matsumura K, Iida M and Kiyohara Y: High-sensitivity C-reactive protein and coronary heart disease in a general population of Japanese: the Hisayama study. Arterioscler Thromb Vasc Biol, 2008; 28: 1385-1391","DOI":"10.1161\/ATVBAHA.107.157164"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Yamanaka H; Japanese Society of Gout and Nucleic Acid Metabolism: Japanese guideline for the management of hyperuricemia and gout: second edition. Nucleosides Nucleotides Nucleic Acids, 2011; 30: 1018-1029","DOI":"10.1080\/15257770.2011.596496"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Kuznik A, Mardekian J and Tarasenko L: Evaluation of cardiovascular disease burden and therapeutic goal attainment in US adults with chronic kidney disease: an analysis of national health and nutritional examination survey data, 2001-2010. BMC Nephrol, 2013; 14: 132","DOI":"10.1186\/1471-2369-14-132"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Lash JP, Go AS, Appel LJ, He J, Ojo A, Rahman M, Townsend RR, Xie D, Cifelli D, Cohan J, Fink JC, Fischer MJ, Gadegbeku C, Hamm LL, Kusek JW, Landis JR, Narva A, Robinson N, Teal V, Feldman HI; Chronic Renal Insufficiency Cohort (CRIC) Study Group: Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function. Clin J Am Soc Nephrol, 2009; 4: 1302-1311","DOI":"10.2215\/CJN.00070109"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Ku E, Lee BJ, Wei J and Weir MR: Hypertension in CKD: Core Curriculum 2019. Am J Kidney Dis, 2019; 74: 120-131","DOI":"10.1053\/j.ajkd.2018.12.044"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Phillips LS, Branch WT, Cook CB, Doyle JP, El-Kebbi IM, Gallina DL, Miller CD, Ziemer DC and Barnes CS: Clinical inertia. Ann Intern Med, 2001; 135: 825-834","DOI":"10.7326\/0003-4819-135-9-200111060-00012"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Tonelli M, Gill J, Pandeya S, Bohm C, Levin A and Kiberd BA: Barriers to blood pressure control and angiotensin enzyme inhibitor use in Canadian patients with chronic renal insufficiency. Nephrol Dial Transplant, 2002; 17: 1426-1433","DOI":"10.1093\/ndt\/17.8.1426"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Nakano T, Tanaka S, Tsuruya K and Kitazono T: Relationship between serum lipid concentrations and impaired renal function in patients with chronic kidney disease: the Fukuoka Kidney Disease Registry Study. Clin Exp Nephrol, 2021; 25: 385-393","DOI":"10.1007\/s10157-020-02000-9"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Wu J, Song Y, Li H and Chen J: Rhabdomyolysis associated with fibrate therapy: review of 76 published cases and a new case report. Eur J Clin Pharmacol, 2009; 65: 1169-1174","DOI":"10.1007\/s00228-009-0723-7"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Schwartz GG, Olsson AG, Abt M, Ballantyne CM, Barter PJ, Brumm J, Chaitman BR, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Mundl H, Nicholls SJ, Shah PK, Tardif JC, Wright RS; dal-OUTCOMES Investigators: Effects of dalcetrapib in patients with a recent acute coronary syndrome. N Engl J Med, 2012; 367: 2089-2099","DOI":"10.1056\/NEJMoa1206797"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Nakamura H, Mizuno K, Ohashi Y, Yoshida T, Hirao K, Uchida Y; MEGA Study Group: Pravastatin and cardiovascular risk in moderate chronic kidney disease. Atherosclerosis, 2009; 206: 512-517","DOI":"10.1016\/j.atherosclerosis.2009.03.031"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Sharp Collaborative Group: Study of Heart and Renal Protection (SHARP): randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease. Am Heart J, 2010; 160: 785-794","DOI":"10.1016\/j.ahj.2010.08.012"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, Wanner C, Krane V, Cass A, Craig J, Neal B, Jiang L, Hooi LS, Levin A, Agodoa L, Gaziano M, Kasiske B, Walker R, Massy ZA, Feldt-Rasmussen B, Krairittichai U, Ophascharoensuk V, Fellstr\u00f6m B, Holdaas H, Tesar V, Wiecek A, Grobbee D, de Zeeuw D, Gr\u00f6nhagen-Riska C, Dasgupta T, Lewis D, Herrington W, Mafham M, Majoni W, Wallendszus K, Grimm R, Pedersen T, Tobert J, Armitage J, Baxter A, Bray C, Chen Y, Chen Z, Hill M, Knott C, Parish S, Simpson D, Sleight P, Young A and Collins R: The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. The Lancet, 2011; 377: 2181-2192","DOI":"10.1016\/S0140-6736(11)60739-3"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Benetos A, Petrovic M and Strandberg T: Hypertension Management in Older and Frail Older Patients. Circ Res, 2019; 124:1045-1060","DOI":"10.1161\/CIRCRESAHA.118.313236"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Japan Diabetes Society (JDS)\/Japan Geriatrics Society (JGS) Joint Committee on Improving Care for Elderly Patients with Diabetes: Glycemic Targets for Elderly Patients with Diabetes. Geriatr Gerontol Int, 2016; 16: 1243-1245","DOI":"10.1111\/ggi.12986"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/30\/9\/30_63891\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T04:50:26Z","timestamp":1693630226000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/30\/9\/30_63891\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,1]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.63891","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,1]]},"article-number":"63891"}}